Arcus Net Income Applicable To Common Shares from 2010 to 2024

RCUS Stock  USD 17.40  0.02  0.11%   
Arcus Biosciences Net Loss yearly trend continues to be comparatively stable with very little volatility. Net Loss is likely to outpace its year average in 2024. Net Loss is the net income that remains after preferred dividends have been deducted, available to common shareholders. View All Fundamentals
 
Net Loss  
First Reported
2016-12-31
Previous Quarter
-75 M
Current Value
-71 M
Quarterly Volatility
66.4 M
 
Covid
Check Arcus Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arcus Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 41 M, Interest Income of 43 M or Depreciation And Amortization of 6.1 M, as well as many indicators such as Price To Sales Ratio of 11.48, Dividend Yield of 0.0 or PTB Ratio of 3.39. Arcus financial statements analysis is a perfect complement when working with Arcus Biosciences Valuation or Volatility modules.
  
Check out the analysis of Arcus Biosciences Correlation against competitors.
For more information on how to buy Arcus Stock please use our How to Invest in Arcus Biosciences guide.

Latest Arcus Biosciences' Net Income Applicable To Common Shares Growth Pattern

Below is the plot of the Net Income Applicable To Common Shares of Arcus Biosciences over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Arcus Biosciences' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arcus Biosciences' overall financial position and show how it may be relating to other accounts over time.
Net Income Applicable To Common Shares10 Years Trend
Slightly volatile
   Net Income Applicable To Common Shares   
       Timeline  

Arcus Net Income Applicable To Common Shares Regression Statistics

Arithmetic Mean(74,585,933)
Geometric Mean47,193,075
Coefficient Of Variation(129.35)
Mean Deviation76,029,778
Median(17,970,000)
Standard Deviation96,473,461
Sample Variance9307.1T
Range319.8M
R-Value(0.70)
Mean Square Error5065.7T
R-Squared0.49
Significance0
Slope(15,171,082)
Total Sum of Squares130299.8T

Arcus Net Income Applicable To Common Shares History

2024-228.3 M
2023-240.3 M
2022-267 M
202152.8 M
2020-122.9 M
2019-84.7 M
2018-49.6 M

About Arcus Biosciences Financial Statements

Arcus Biosciences shareholders use historical fundamental indicators, such as Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Arcus Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Arcus Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Arcus Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss-240.3 M-228.3 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Arcus Stock Analysis

When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.